Massimo Napolitano

573 total citations
16 papers, 349 citations indexed

About

Massimo Napolitano is a scholar working on Neurology, Genetics and Oncology. According to data from OpenAlex, Massimo Napolitano has authored 16 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Massimo Napolitano's work include Autoimmune Neurological Disorders and Treatments (5 papers), Glioma Diagnosis and Treatment (5 papers) and Multiple Sclerosis Research Studies (4 papers). Massimo Napolitano is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (5 papers), Glioma Diagnosis and Treatment (5 papers) and Multiple Sclerosis Research Studies (4 papers). Massimo Napolitano collaborates with scholars based in Italy, France and Austria. Massimo Napolitano's co-authors include Florence Keime-Guibert, J. Y. Delattre, Giorgia Teresa Maniscalco, Alain Carpentier, Khê Hoang‐Xuan, Jean Cougnard, Karima Mokhtari, Stéphanie Cartalat‐Carel, J.‐Y. Delattre and Marc Sanson and has published in prestigious journals such as Neurology, Cancer Letters and Journal of Neurology.

In The Last Decade

Massimo Napolitano

14 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Napolitano Italy 9 164 149 82 53 49 16 349
Winny Varikatt Australia 14 93 0.6× 92 0.6× 57 0.7× 89 1.7× 75 1.5× 44 404
R. Bradford United Kingdom 13 177 1.1× 186 1.2× 107 1.3× 57 1.1× 73 1.5× 28 455
Monique C.J. Hanse Netherlands 11 202 1.2× 137 0.9× 152 1.9× 46 0.9× 70 1.4× 20 376
Paweł Daszkiewicz Poland 12 158 1.0× 57 0.4× 87 1.1× 37 0.7× 66 1.3× 44 464
Johannes Weller Germany 12 205 1.3× 173 1.2× 75 0.9× 95 1.8× 78 1.6× 60 430
Chiara Bosa Italy 9 126 0.8× 44 0.3× 60 0.7× 27 0.5× 29 0.6× 16 241
Marcel Seiz‐Rosenhagen Germany 11 105 0.6× 80 0.5× 94 1.1× 26 0.5× 83 1.7× 24 277
Laurèl Rauschenbach Germany 14 155 0.9× 87 0.6× 290 3.5× 47 0.9× 81 1.7× 79 540
Mary K. Gumerlock United States 9 160 1.0× 63 0.4× 158 1.9× 54 1.0× 33 0.7× 15 363
George Sfakianos Greece 15 179 1.1× 51 0.3× 160 2.0× 36 0.7× 69 1.4× 51 512

Countries citing papers authored by Massimo Napolitano

Since Specialization
Citations

This map shows the geographic impact of Massimo Napolitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Napolitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Napolitano more than expected).

Fields of papers citing papers by Massimo Napolitano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Napolitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Napolitano. The network helps show where Massimo Napolitano may publish in the future.

Co-authorship network of co-authors of Massimo Napolitano

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Napolitano. A scholar is included among the top collaborators of Massimo Napolitano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Napolitano. Massimo Napolitano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Maniscalco, Giorgia Teresa, Antonietta Liotti, Anne Lise Ferrara, et al.. (2022). Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies. Multiple Sclerosis and Related Disorders. 68. 104371–104371. 8 indexed citations
2.
Maniscalco, Giorgia Teresa, Valentino Manzo, Massimo Napolitano, et al.. (2021). Autoimmune encephalitis: A retrospective monocentric experience. Multiple Sclerosis and Related Disorders. 55. 103191–103191. 2 indexed citations
3.
Maniscalco, Giorgia Teresa, Αναστασία Ζεκερίδου, Angelo Ranieri, et al.. (2021). GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation. Neurological Sciences. 42(10). 4289–4291. 12 indexed citations
4.
Napolitano, Massimo, et al.. (2021). Paraneoplastic Cerebellar Degeneration Associated with Anti-Yo Antibodies Appearing as a Leptomeningeal Cerebellar Carcinomatosis at MRI: a Case Report. SN Comprehensive Clinical Medicine. 3(11). 2329–2331. 2 indexed citations
5.
Maniscalco, Giorgia Teresa, Sara Mariotto, Romana Höftberger, et al.. (2020). GABA A receptor autoimmunity after alemtuzumab treatment for multiple sclerosis. Neurology. 95(9). 399–401. 11 indexed citations
6.
Napolitano, Massimo, et al.. (2020). Brain Radionecrosis After Adjuvant Radiation Therapy for a Primary Intracerebral Undifferentiated Sarcoma. World Neurosurgery. 143. 285–288. 1 indexed citations
7.
Maniscalco, Giorgia Teresa, Massimo Napolitano, Angelo Ranieri, et al.. (2020). Anti-MOG-associated demyelinating disorders: two sides of the same coin. Neurological Sciences. 42(4). 1531–1534. 12 indexed citations
8.
Ranieri, Angelo, Massimo Napolitano, Katia Longo, et al.. (2020). One year experience with erenumab: real-life data in 30 consecutive patients. Neurological Sciences. 41(S2). 505–506. 11 indexed citations
9.
10.
Maniscalco, Giorgia Teresa, I. Cerillo, Massimo Napolitano, et al.. (2018). Early neutropenia with thrombocytopenia following alemtuzumab treatment for multiple sclerosis: case report and review of literature. Clinical Neurology and Neurosurgery. 175. 134–136. 13 indexed citations
11.
Maniscalco, Giorgia Teresa, et al.. (2017). THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study. Neurological Sciences. 39(1). 97–102. 20 indexed citations
12.
Sanson, Marc, Stéphanie Cartalat‐Carel, Sophie Taillibert, et al.. (2004). Initial chemotherapy in gliomatosis cerebri. Neurology. 63(2). 270–275. 75 indexed citations
13.
Napolitano, Massimo, Florence Keime-Guibert, A. Monjour, et al.. (1999). Treatment of Supratentorial Glioblastoma Multiforme with Radiotherapy and a Combination of BCNU and Tamoxifen: A Phase II Study. Journal of Neuro-Oncology. 45(3). 229–235. 13 indexed citations
14.
Keime-Guibert, Florence, Massimo Napolitano, & J. Y. Delattre. (1998). Neurological complications of radiotherapy and chemotherapy. Journal of Neurology. 245(11). 695–708. 163 indexed citations
15.
D’Angelo, V., et al.. (1997). Surgical treatment of anterior callosal tumors.. PubMed. 41(1). 117–22. 3 indexed citations
16.
Nigro, Vincenzo, Massimo Napolitano, Ciro Abbondanza, et al.. (1994). A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis. Cancer Letters. 79(1). 73–75. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Winny Varikatt Breakdown of academic impact, for papers by R. Bradford Breakdown of academic impact, for papers by Monique C.J. Hanse Breakdown of academic impact, for papers by Paweł Daszkiewicz Breakdown of academic impact, for papers by Johannes Weller Breakdown of academic impact, for papers by Chiara Bosa Breakdown of academic impact, for papers by Marcel Seiz‐Rosenhagen Breakdown of academic impact, for papers by Laurèl Rauschenbach Breakdown of academic impact, for papers by Mary K. Gumerlock Breakdown of academic impact, for papers by George Sfakianos
Rankless by CCL
2026